OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $29,000 | -85.8% | 14,200 | -65.7% | 0.00% | -66.7% |
Q2 2015 | $204,000 | -37.0% | 41,400 | 0.0% | 0.00% | -40.0% |
Q1 2015 | $324,000 | +16.5% | 41,400 | -10.0% | 0.01% | +25.0% |
Q4 2014 | $278,000 | -1.8% | 46,000 | -30.8% | 0.00% | +33.3% |
Q3 2014 | $283,000 | – | 66,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 525,000 | $2,956,000 | 1.06% |
First Light Asset Management, LLC | 170,804 | $962,000 | 0.82% |
PFM Health Sciences, LP | 5,047,119 | $28,415,000 | 0.57% |
Rhenman & Partners Asset Management AB | 250,000 | $1,408,000 | 0.55% |
NEA Management Company, LLC | 1,935,300 | $10,896,000 | 0.53% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 544,779 | $3,067,000 | 0.43% |
APEX CAPITAL, LLC | 1,000,000 | $5,630,000 | 0.37% |
Partner Investment Management, L.P. | 240,221 | $1,352,000 | 0.31% |
Hudson Bay Capital Management LP | 1,002,405 | $5,644,000 | 0.23% |
BAILARD, INC. | 243,300 | $1,370,000 | 0.22% |